Abstract
Psoriasis is a chronic inflammatory disease associated with an increased insulin resistance, obesity and cardiovascular risk. The present study was aimed to assess insulin resistance and pattern of body fat deposition in psoriasis. Body mass index (BMI) and waist circumference (WC) were measured in 40 psoriatic patients and 46 age- and sex-matched control subjects. Fasting blood glucose (FBG) and serum insulin level were measured by standard photometric method and ELISA respectively. HOMA-IR (homeostatic model of insulin resistance) was calculated by appropriate software. The results indicated that case and control groups were comparable in terms of age and sex (p = 0.934) with an increased prevalence of psoriasis among male subjects (60 %). FBG and mean WC between the two groups were statistically not significant (p value = 0.271 and 0.21 respectively). BMI was significantly higher in case group compared to the control group (p = 0.049). Serum insulin level and insulin resistance in the psoriatic patients were significantly higher (p value <0.001). Multiple regression analysis revealed that insulin resistance (measured by HOMA) was dependent on BMI and WC at a significance level of p < 0.001 and 0.043 respectively. Therefore, the psoriatic patients in this region have significantly high amount of fasting serum insulin level along with an increased IR though their FBG level remains normal. Furthermore, these abnormalities are significantly dependent on total body fat as well as abdominal fat deposits. We suggest that psoriatic patients need to be evaluated for metabolic syndrome and managed accordingly.
Similar content being viewed by others
References
Prieto-Pérez R, Cabaleiro T, Daudén E, Ochoa D, Roman M, Abad-Santos F. Genetics of psoriasis and pharmacogenetics of biological drugs. Autoimmune Dis. 2013;2013:613086.
Freilich AR. Tzaraat-“biblical leprosy”. J Am Acad Dermatol. 1982;6(1):131–4.
Gelfand JM, Stern RS, Nijsten T. The prevalence of psoriasis in African Americans: results from a population-based study. J Am Acad Dermatol. 2005;52(1):23–6.
Gelfand JM, Weinstein R, Porter SB, Neimann AL, Berlin JA, Margolis DJ. Prevalence and treatment of psoriasis in the United Kingdom: a population-based study. Arch Dermatol. 2005;141(12):1537–41.
Henseler T, Christophers E. Disease concomitance in psoriasis. J Am Acad Dermatol. 1995;32:982–6.
Neimann AL, Shin DB, Wang Xe. Prevalence of cardiovascular risk factors in patients with psoriasis. J Am Acad Dermatol. 2006;55:829–35.
Mallbris L, Ritchlin CT, Stahle M. Metabolic disorders in patients with Psoriasis and Psoriatic arthritis. Curr Rheumatol Rep. 2006;8:355–63.
Boehncke S, Thaci D, Beschmann H, Ludwig RJ, Ackermann H, Badenhoop K, et al. Psoriasis patients show signs of insulin resistance. Br J Dermatol. 2007;157:1249–51.
Wellen KE, Hotamisligil GS. Inflammation, stress, and diabetes. J Clin Invest. 2005;115:1111–9.
Naldi L, Chatenoud L, Linder De. Cigarette smoking, body mass index, and stressful life events as risk factor for psoriasis: results from an Italian case control study. J Invest Dermatol. 2005;125:61–7.
Boehncke S, Thaci D, Besschmann H, Ludwig R, Ackermann H, Badenhoop K, et al. Psoriasis patients show signs of insulin resistance. Br J Dermatol. 2007;157(6):1249–51.
Li R, Krishnamoorthy P, Raper A, Baer A, Derohannessions S, Wilcox M, et al. Psoriasis is associated with decreased adiponectin levels beyond cardiovascular and metabolic risk factors. Endocr Abstr. 2012;29:338.
Gisondi P, Tessari G, ContiA PS, Schianchi S, Peserico A, Giannetti A, et al. Prevalence of metabolic syndrome in patients with psoriasis: a hospital based case control study. Br J Dermatol. 2007;157:68–73.
Sterry W, Strober BE, Menter. Obesity in psoriasis; the metabolic clinical and therapeutic implication; report of an interdisciplinary conference and review. Br J Dermatol. 2007;157(4):649–55.
Bernelli S, Moraes A, Monte-Alegre S, Carvalho O, Saad M. Insulin resistance in psoriasis. Braz J Med Biol Res. 1995;28(3):297–301.
Pereira R, Amaladi S, Varthakavi P. A study of the prevalence of diabetes, insulin resistance, lipid abnormality and cardiovascular risk factors in patients with chr plaque psoriasis. Indian J Dermatol. 2011;56(5):520–6.
Sacks DB. Carbohydrate. In: Burtis CA, Ashwood ER, Bruns DE, editors. Tietz fundamentals of clinical chemistry. 4th ed. New Delhi: Saunders; 2008. p. 870.
Wahernberg H, Hertel K, Leijonhufvud BM, Persson LG, Toft E, Arner P. Use of waist circumference to predict insulin resistance: retrospective study. BMJ. 2005;330:1363.
Frayn KN. Visceral fat and insulin resistance–causative or correlative? Br J Nutr. 2000;83(Suppl 1):S71–7.
Klein S. The case of visceral fat: argument for the defense. J Clin Invest. 2004;113(11):1530.
Fontana L, Eagon JC, Trujillo ME, Scherer PE, Klein S. Visceral fat adipokine secretion is associated with systemic inflammation in obese humans. Diabetes. 2007;56(4):1010–3.
Sikora-Grabka E, Adamczak M, Wiecek A. Metabolic disorders in patients with psoriasis. Przegl Lek. 2011;68(12):1193–8.
Siegel D, Devaraj S, Mitra A, Raychaudhuri SP, Raychaudhuri SK, Jialal I. Inflammation, atherosclerosis, and psoriasis. Clin Rev Allergy Immunol. 2013;44(2):194–204. doi:10.1007/s12016-012-8308-0.
Gustafson B, Hammarstedt A, Andersson C, Smith U. Inflammed adipose tissue: a culprit underlying the metabolic syndrome and atherosclerosis. Arter Thromb Vasc Biol. 2007;27(11):2276–83.
Wakkee M, Thiol H, Prens Eea. Unfavorable cardiovascular risk profiles in untreated and treated psoriasis patients. Atherosclerosis. 2007;190:1–7.
Romanowska M, al Yacoub N, Seidel H, Donandt S, Garken H, Philip S, et al. PPAR delta enhances keratinocyte proliferation in psoriasis and induces heparin-binding EGF-like growth factor. J Invest Dermatol. 2008;128(1):110–24.
Kahn BB, Flier JS. Obesity and insulin resistance. J Clin Invest. 2000;106(4):473–81.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Dhara, S., Dasgupta, A., Rout, J.K. et al. Clinico-Biochemical Correlation Between Psoriasis and Insulin Resistance. Ind J Clin Biochem 30, 99–103 (2015). https://doi.org/10.1007/s12291-013-0413-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12291-013-0413-1